Skip to main content
U.S. flag

An official website of the United States government

Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model

Bibliographic

Year of Publication:
2018
Contact PI Name:
Rudolph E. Tanzi
Contact PI Affiliation:
Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA
Co-Authors:
S.H. Choi, E. Bylykbashi, Z.K. Chatila, S.W. Lee, B. Pulli, G.D. Clemenson, E. Kim, A. Rompala, M.K. Oram, C. Asselin, J. Aronson, C. Zhang, S.J. Miller, A. Lesinski, J.W. Chen, D.Y. Kim, H. van Praag, B.M. Spiegelman, F.H. Gage
Primary Reference (PubMED ID):
Funding Source:
National Institute on Aging (NIA)
National Institute of Mental Health (NIMH)
Cure Alzheimer’s Fund
Henry and Allison McCance Center for Brain Health
JPB Foundation
The Leona M. and Harry B. Helmsley Charitable Trust
Mather’s Foundation
Study Goal and Principal Findings:

Adult hippocampal neurogenesis (AHN) is impaired before the onset of Alzheimer’s disease (AD) pathology. We found that exercise provided cognitive benefit to 5×FAD mice, a mouse model of AD, by inducing AHN and elevating levels of brain-derived neurotrophic factor (BDNF). Neither stimulation of AHN alone, nor exercise, in the absence of increased AHN, ameliorated cognition. We successfully mimicked the beneficial effects of exercise on AD mice by genetically and pharmacologically inducing AHN in combination with elevating BDNF levels. Suppressing AHN later led to worsened cognitive performance and loss of preexisting dentate neurons. Thus, pharmacological mimetics of exercise, enhancing AHN and elevating BDNF levels, may improve cognition in AD. Furthermore, applied at early stages of AD, these mimetics may protect against subsequent neuronal cell death.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Biologic - Gene
Therapeutic Agent:
Lentivirus-Wnt3
Therapeutic Target:
Multi Target
Therapy Type:
Small Molecule
Therapeutic Agent:
Aminopropyl Carbazole (P7C3)
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APPxPS1
Strain/Genetic Background:
C57BL6/SJL

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest
Experiment Notes

Inclusion/Exclusion criteria are detailed in the supplemental information.

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Delayed Nonmatching to Place (DNMP)
Exploratory Activity
Radial Arm Maze
Spontaneous Alternation
Y Maze
Motor Function
Locomotor Activity
Histopathology
beta Amyloid Deposits
beta Amyloid Load
Neuronal Loss
phospho-Tau
Activated Microglia
Biochemical
Brain-Derived Neurotrophic Factor (BDNF)
Interferon (IFN) gamma
Interleukin 1 beta (IL-1 beta)
Interleukin 2 (IL-2)
Interleukin 4 (IL-4)
Interleukin 5 (IL-5)
Interleukin 6 (IL-6)
Interleukin 10 (IL-10)
Interleukin 12p70 (IL-12p70)
Postsynaptic Density Protein 95 (PSD95)
Synapse-Associated Protein 97 (SAP97)
Synaptophysin
Tumor Growth Factor beta (TGF beta)
Tumor Necrosis Factor alpha (TNF alpha)
Fibronectin Type III Domain-Containing Protein 5 (FNDC5)
Keratinocyte Chemoattractant/Growth-Regulated Oncogene (KC/GRO)
Immunochemistry
Brain-beta Amyloid Deposits
5-bromo-2’-deoxyuridine (BrdU)
Caspase 3
Cleaved Caspase 3
Cell Proliferation
Doublecortin (DCX)
Glial Fibrillary Acidic Protein (GFAP)
Ionized Calcium Binding Adaptor Molecule 1 (Iba1)
Neuronal Marker NeuN
phospho-Tau
Microscopy
Dendritic Arborization
Dendritic Length
Dendritic Spine Density
Neuronal Cell Number
Neuronal Loss
Stereology
Cell Biology
Cell Viability
FACS Analysis